BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23043291)

  • 41. In vitro Leishmanicidal and Trypanosomicidal Properties of Imidazole-Containing Azine and Benzoazine Derivatives.
    Martín-Montes Á; Kolodová K; Marín C; Rosales-Lombardo MJ; Sánchez-Moreno M; de Andrés-Gordo L; Cano C; Campayo L; Gómez-Muñoz A; Sanz AM; Yunta MJR
    ChemMedChem; 2021 Dec; 16(23):3600-3614. PubMed ID: 34665510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and biological evaluation of N,N'-squaramides with high in vivo efficacy and low toxicity: toward a low-cost drug against Chagas disease.
    Olmo F; Rotger C; Ramírez-Macías I; Martínez L; Marín C; Carreras L; Urbanová K; Vega M; Chaves-Lemaur G; Sampedro A; Rosales MJ; Sánchez-Moreno M; Costa A
    J Med Chem; 2014 Feb; 57(3):987-99. PubMed ID: 24410674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi.
    Esteva MI; Kettler K; Maidana C; Fichera L; Ruiz AM; Bontempi EJ; Andersson B; Dahse HM; Haebel P; Ortmann R; Klebe G; Schlitzer M
    J Med Chem; 2005 Nov; 48(23):7186-91. PubMed ID: 16279776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
    Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
    Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
    Ceole LF; Gandhi H; Villamizar LH; Soares MJ; O'Sullivan TP
    Future Med Chem; 2018 Feb; 10(4):391-408. PubMed ID: 29380636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
    Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
    Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trypanocidal activity and selectivity in vitro of aromatic amidine compounds upon bloodstream and intracellular forms of Trypanosoma cruzi.
    De Souza EM; da Silva PB; Nefertiti AS; Ismail MA; Arafa RK; Tao B; Nixon-Smith CK; Boykin DW; Soeiro MN
    Exp Parasitol; 2011 Feb; 127(2):429-35. PubMed ID: 20971106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.
    Quebrada Palacio LP; González MN; Hernandez-Vasquez Y; Perrone AE; Parodi-Talice A; Bua J; Postan M
    PLoS One; 2018; 13(9):e0203462. PubMed ID: 30183775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
    Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N
    Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives.
    Estevez Y; Quiliano M; Burguete A; Cabanillas B; Zimic M; Málaga E; Verástegui M; Pérez-Silanes S; Aldana I; Monge A; Castillo D; Deharo E
    Exp Parasitol; 2011 Apr; 127(4):745-51. PubMed ID: 21272583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dimeric flavonoids from Arrabidaea brachypoda and assessment of their anti-Trypanosoma cruzi activity.
    da Rocha CQ; Queiroz EF; Meira CS; Moreira DR; Soares MB; Marcourt L; Vilegas W; Wolfender JL
    J Nat Prod; 2014 Jun; 77(6):1345-50. PubMed ID: 24871307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.
    Benaim G; Sanders JM; Garcia-Marchán Y; Colina C; Lira R; Caldera AR; Payares G; Sanoja C; Burgos JM; Leon-Rossell A; Concepcion JL; Schijman AG; Levin M; Oldfield E; Urbina JA
    J Med Chem; 2006 Feb; 49(3):892-9. PubMed ID: 16451055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives.
    Paucar R; Martín-Escolano R; Moreno-Viguri E; Cirauqui N; Rodrigues CR; Marín C; Sánchez-Moreno M; Pérez-Silanes S; Ravera M; Gabano E
    Eur J Med Chem; 2019 Feb; 163():569-582. PubMed ID: 30554132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes.
    Caballero AB; Marín C; Rodríguez-Diéguez A; Ramírez-Macías I; Barea E; Sánchez-Moreno M; Salas JM
    J Inorg Biochem; 2011 Jun; 105(6):770-6. PubMed ID: 21497152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies.
    Rodríguez J; Arán VJ; Boiani L; Olea-Azar C; Lavaggi ML; González M; Cerecetto H; Maya JD; Carrasco-Pozo C; Cosoy HS
    Bioorg Med Chem; 2009 Dec; 17(24):8186-96. PubMed ID: 19900812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Kaiser M
    Eur J Med Chem; 2014 Nov; 87():79-88. PubMed ID: 25240098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity.
    Moreira DR; Leite AC; Cardoso MV; Srivastava RM; Hernandes MZ; Rabello MM; da Cruz LF; Ferreira RS; de Simone CA; Meira CS; Guimaraes ET; da Silva AC; dos Santos TA; Pereira VR; Soares MB
    ChemMedChem; 2014 Jan; 9(1):177-88. PubMed ID: 24203393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-trypanosomal activity of (8-hydroxymethylen)-trieicosanyl acetate against infective forms of Trypanosoma cruzi.
    Jimenez-Coello M; Acosta-Viana KY; Guzman-Marin E; Perez Gonzalez C; Salud Perez Gutierrez M
    Pharm Biol; 2010 Jun; 48(6):666-71. PubMed ID: 20645740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural investigation of anti-Trypanosoma cruzi 2-iminothiazolidin-4-ones allows the identification of agents with efficacy in infected mice.
    Moreira DR; Costa SP; Hernandes MZ; Rabello MM; de Oliveira Filho GB; de Melo CM; da Rocha LF; de Simone CA; Ferreira RS; Fradico JR; Meira CS; Guimarães ET; Srivastava RM; Pereira VR; Soares MB; Leite AC
    J Med Chem; 2012 Dec; 55(24):10918-36. PubMed ID: 23167554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New Imidazole-Based Compounds Active Against Trypanosoma cruzi.
    Adeyemi OS; Molina MT; Eseola AO; Fonseca-Berzal C; Gómez-Barrio A
    Comb Chem High Throughput Screen; 2017; 20(1):20-24. PubMed ID: 28071587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.